Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis

Development of cardiac manifestations in patients diagnosed with inflammatory bowel disease undergoing treatment with mesalamine is a rare. When this occurs, it can be difficult to tease out the primary etiology, as both IBD and mesalamine can cause cardiac manifestations independently of each other...

Full description

Saved in:
Bibliographic Details
Main Authors: Kelechukwu U. Okoro, Matthew D. Roby, Adegbenga A. Bankole
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2018/9813893
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566780229320704
author Kelechukwu U. Okoro
Matthew D. Roby
Adegbenga A. Bankole
author_facet Kelechukwu U. Okoro
Matthew D. Roby
Adegbenga A. Bankole
author_sort Kelechukwu U. Okoro
collection DOAJ
description Development of cardiac manifestations in patients diagnosed with inflammatory bowel disease undergoing treatment with mesalamine is a rare. When this occurs, it can be difficult to tease out the primary etiology, as both IBD and mesalamine can cause cardiac manifestations independently of each other. The exact mechanism of mesalamine-induced cardiotoxicity is yet to be determined although several mechanisms have been described. We present the case of a gentleman with nonexertional chest pain in the setting of ulcerative colitis exacerbation believed to have occurred secondary to mesalamine.
format Article
id doaj-art-b311d672ec8b4c0f8af5d3b5344b6b39
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-b311d672ec8b4c0f8af5d3b5344b6b392025-02-03T01:03:21ZengWileyCase Reports in Medicine1687-96271687-96352018-01-01201810.1155/2018/98138939813893Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative ColitisKelechukwu U. Okoro0Matthew D. Roby1Adegbenga A. Bankole2Department of Internal Medicine, Virginia Tech Carilion School of Medicine and Research Institute, Roanoke, VA, USADepartment of Internal Medicine, Section of Cardiology, Virginia Tech Carilion School of Medicine and Research Institute, Raonoke, VA, USADepartment of Internal Medicine, Section of Rheumatology, Virginia Tech Carilion School of Medicine and Research Institute, Raonoke, VA, USADevelopment of cardiac manifestations in patients diagnosed with inflammatory bowel disease undergoing treatment with mesalamine is a rare. When this occurs, it can be difficult to tease out the primary etiology, as both IBD and mesalamine can cause cardiac manifestations independently of each other. The exact mechanism of mesalamine-induced cardiotoxicity is yet to be determined although several mechanisms have been described. We present the case of a gentleman with nonexertional chest pain in the setting of ulcerative colitis exacerbation believed to have occurred secondary to mesalamine.http://dx.doi.org/10.1155/2018/9813893
spellingShingle Kelechukwu U. Okoro
Matthew D. Roby
Adegbenga A. Bankole
Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
Case Reports in Medicine
title Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
title_full Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
title_fullStr Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
title_full_unstemmed Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
title_short Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
title_sort myocarditis secondary to mesalamine induced cardiotoxicity in a patient with ulcerative colitis
url http://dx.doi.org/10.1155/2018/9813893
work_keys_str_mv AT kelechukwuuokoro myocarditissecondarytomesalamineinducedcardiotoxicityinapatientwithulcerativecolitis
AT matthewdroby myocarditissecondarytomesalamineinducedcardiotoxicityinapatientwithulcerativecolitis
AT adegbengaabankole myocarditissecondarytomesalamineinducedcardiotoxicityinapatientwithulcerativecolitis